Metamizole Sodium, Solution for Injection, 500 Tender - 151702726

Procurement Summary

Country: Ukraine

Summary: Metamizole Sodium, Solution for Injection, 500 Mg/Ml, 2 Ml; Magnesium Sulfate, Solution for Injection, 250 Mg/Ml, 5 Ml Each; Ibuprofen Tablets/Capsules of 200 Mg; Furosemide, Solution for Injection, 10 Mg/Ml, 2 Ml Each;...

Deadline: 02 Nov 2026

Posting Date: 30 Oct 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 151702726

Document Ref. No.: UA-2026-10-28-012819-a

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: UAH 28037.38

CPV Classification

33600000 - Pharmaceutical products
33660000 - Medicinal products for the nervous system and sensory organs
33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system
33630000 - Medicinal products for dermatology and the musculo-skeletal system

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Metamizole sodium, solution for injection, 500 mg/ml, 2 ml; Magnesium sulfate, solution for injection, 250 mg/ml, 5 ml each; Ibuprofen tablets/capsules of 200 mg; Furosemide, solution for injection, 10 mg/ml, 2 ml each; Ethyl alcohol 70% 100 ml.; Paracetamol tablets/capsules 500 mg; Hydrogen peroxide, solution, 3%, 100 ml; Barbiturates in combination (ethyl ether of a-bromosovaleric acid 12.42 mg, phenobarbital 11.34 mg, menthol solution in menthyl ether of isovaleric acid 46 mg) in capsules; Chlorhexidine, solution for external use 0.05% per 100 ml
Type of procurement: goods Classifier and its corresponding code: DK 021:2015: 33600000-6 — Pharmaceutical products Paracetamol tablets/capsules 500 mg; Classification according to ATC: N05CB02, Classification according to INN: Barbiturates in combination with other drugs, Release form: Capsules, Type of packaging: Blister, Ethyl ether of alpha-bromosovaleric acid: 10 mg, Phenobarbital: 9.8 mg, Menthol solution in isovaleric acid menthyl ether (validol): 46 mg; Classification according to ATX: D08AC02, INN: Chlorhexidine, Release form: Solution for external use, Dose of active substance: 0.05%, Volume: 100 ml, Type of packaging: Vial NameClassifier and its corresponding codeQuantity/Measurement unitsPlace of deliveryDate of deliveryName
Classification according to ATX: N05CB02, Classification according to INN: Barbiturates in combination with other drugs, Release form: Capsules, Type of packaging: Blister, Ethyl ether of alpha-bromosovaleric acid: 10 mg, Phenobarbital: 9.8 mg, Menthol solution in menthyl ether of isovaleric acid (validol): 46 mg; Classification according to ATX: D08AC02, INN: Chlorhexidine, Release form: Solution for external use, Dose of the active substance: 0.05%, Volume: 100 ml, Type of packaging: Vial NameClassifier and its corresponding codeQuantity/Units of measurementPlace of deliveryDate of deliveryName

Documents

 Tender Notice